La régulation du secteur pharmaceutique dans l’espace UEMOA : des législations nationales vers un cadre juridique communautaire à fort impact

Abstract

Given the need to pool resources in the face of the multiple challenges of the pharmaceutical sector, many initiatives have been taken by WAEMU since the 2000s with a view to optimizing the regulation of the pharmaceutical sector in the Union. Regulation No. 02/2005/CM/UEMOA remains the founding text of pharmaceutical regulations in the WAEMU area. It was implemented through the adoption of other community texts relating in particular to pharmaceutical products, but also to the profession and pharmaceutical activity. Alongside the WAEMU community regulations concerning veterinary medicinal products, initiatives to harmonize pharmaceutical regulations within WAEMU concerning pharmaceutical products for human use have had a significant impact in member countries and are likely to promote better protection of public health. Based on the available documentation, on the regulatory texts applicable to the pharmaceutical sector of the UEMOA space, this article describes the process of implementation of this community regulation and its scope.